UFPT vs. ABBV

Last updated Jun 3, 2026

UFPT (UFP Technologies, Inc.) and ABBV (AbbVie Inc.) are both stocks. Both are in the Healthcare sector — UFPT in Medical Devices, ABBV in Drug Manufacturers - General. Over the past 10 years, UFPT returned 26.22%/yr vs 17.47%/yr for ABBV. At a 0.16 correlation, their price movements are largely independent.

Performance

UFPT vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in UFP Technologies, Inc. (UFPT) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, UFPT achieves a -2.54% return, which is significantly higher than ABBV's -4.18% return. Over the past 10 years, UFPT has outperformed ABBV with an annualized return of 26.22%, while ABBV has yielded a comparatively lower 17.47% annualized return.

UFPT

• 1D: -0.80%
• 1M: 11.50%
• YTD: -2.54%
• 6M: -1.23%
• 1Y: -6.81%
• 3Y*: 10.62%
• 5Y*: 30.21%
• 10Y*: 26.22%

ABBV

• 1D: 1.16%
• 1M: 4.26%
• YTD: -4.18%
• 6M: -2.42%
• 1Y: 18.95%
• 3Y*: 20.56%
• 5Y*: 18.28%
• 10Y*: 17.47%

*Multi-year figures are annualized to reflect compound growth (CAGR)

UFPT vs. ABBV - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
UFPT UFP Technologies, Inc.	-2.54%	-9.19%	42.12%	45.93%	67.79%	50.77%	-6.07%	65.15%	8.06%	9.23%
ABBV AbbVie Inc.	-4.18%	33.08%	18.86%	-0.23%	24.01%	32.43%	27.72%	1.47%	-0.96%	60.07%

Correlation

The correlation between UFPT and ABBV is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.12
Correlation (3Y) Calculated over the trailing 3-year period	0.08
Correlation (5Y) Calculated over the trailing 5-year period	0.11
Correlation (10Y) Calculated over the trailing 10-year period	0.13
Correlation (All Time) Calculated using the full available price history since Jan 3, 2013	0.16

Fundamentals

Market Cap UFPT : $1.69B ABBV : $382.12B
EPS UFPT : $8.81 ABBV : $2.05
PE Ratio UFPT : 24.56 ABBV : 104.95
PS Ratio UFPT : 2.77 ABBV : 6.08
PB Ratio UFPT : 3.85 ABBV : 13.90
Total Revenue (TTM) UFPT : $608.85M ABBV : $62.82B
Gross Profit (TTM) UFPT : $172.62M ABBV : $46.15B
EBITDA (TTM) UFPT : $111.39M ABBV : $17.96B

Return for Risk

UFPT vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UFPT

UFPT Risk / Return Rank: 32
UFPT Sharpe Ratio Rank: 34
UFPT Sortino Ratio Rank: 31
UFPT Omega Ratio Rank: 31
UFPT Calmar Ratio Rank: 32
UFPT Martin Ratio Rank: 32

ABBV

ABBV Risk / Return Rank: 62
ABBV Sharpe Ratio Rank: 66
ABBV Sortino Ratio Rank: 59
ABBV Omega Ratio Rank: 58
ABBV Calmar Ratio Rank: 63
ABBV Martin Ratio Rank: 63

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UFPT vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for UFP Technologies, Inc. (UFPT) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	UFPT	ABBV	Difference
Sharpe ratio Return per unit of total volatility	-0.16	0.79	-0.95
Sortino ratio Return per unit of downside risk	0.08	1.25	-1.18
Omega ratio Gain probability vs. loss probability	1.01	1.16	-0.15
Calmar ratio Return relative to maximum drawdown	-0.25	1.13	-1.37
Martin ratio Return relative to average drawdown	-0.46	2.54	-3.00
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

UFPT vs. ABBV - Sharpe Ratio Comparison

The current UFPT Sharpe Ratio is -0.16, which is lower than the ABBV Sharpe Ratio of 0.79. The chart below compares the historical Sharpe Ratios of UFPT and ABBV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	UFPT	ABBV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.16	0.79	-0.95
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.69	0.80	-0.12
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.66	0.68	-0.02
Sharpe Ratio (All Time) Calculated using the full available price history	0.16	0.73	-0.57

Drawdowns

UFPT vs. ABBV - Drawdown Comparison

The maximum UFPT drawdown since its inception was -88.53%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for UFPT and ABBV.

Drawdown Indicators

	UFPT	ABBV	Difference
Max Drawdown Largest peak-to-trough decline	-88.53%	-45.09%	-43.44%
Max Drawdown (1Y) Largest decline over 1 year	-30.69%	-17.32%	-13.37%
Max Drawdown (3Y) Largest decline over 3 years	-48.31%	-20.74%	-27.57%
Max Drawdown (5Y) Largest decline over 5 years	-48.31%	-21.92%	-26.39%
Max Drawdown (10Y) Largest decline over 10 years	-48.31%	-45.09%	-3.22%
Current Drawdown Current decline from peak	-39.63%	-9.77%	-29.86%
Average Drawdown Average peak-to-trough decline	-32.24%	-10.73%	-21.51%
Ulcer Index Depth and duration of drawdowns from previous peaks	16.65%	7.67%	+8.98%

Volatility

UFPT vs. ABBV - Volatility Comparison

UFP Technologies, Inc. (UFPT) has a higher volatility of 13.56% compared to AbbVie Inc. (ABBV) at 5.42%. This indicates that UFPT's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	UFPT	ABBV	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.56%	5.42%	+8.14%
Volatility (6M) Calculated over the trailing 6-month period	30.24%	17.63%	+12.61%
Volatility (1Y) Calculated over the trailing 1-year period	43.48%	23.95%	+19.53%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	44.22%	22.84%	+21.38%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	39.61%	25.74%	+13.87%

Dividends

UFPT vs. ABBV - Dividend Comparison

UFPT has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 3.13%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ABBV AbbVie Inc.	3.13%	2.87%	3.49%	3.82%	3.49%	3.84%	4.41%	4.83%	3.89%	2.65%	3.64%	3.41%
UFPT UFP Technologies, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

UFPT vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between UFP Technologies, Inc. and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

UFPT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, UFP Technologies, Inc. reported a gross profit of 44.36M and revenue of 154.20M. Therefore, the gross margin over that period was 28.8%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.

UFPT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, UFP Technologies, Inc. reported an operating income of 23.37M and revenue of 154.20M, resulting in an operating margin of 15.2%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.

UFPT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, UFP Technologies, Inc. reported a net income of 17.50M and revenue of 154.20M, resulting in a net margin of 11.4%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.

Frequently Asked Questions

Can I hold both UFPT and ABBV in my portfolio?

UFPT and ABBV have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, UFPT or ABBV?

UFPT has higher volatility (13.56%) compared to ABBV (5.42%). In terms of maximum drawdown, UFPT dropped -88.53% vs ABBV's -45.09%.

Which has better risk-adjusted returns?

ABBV currently has the higher Sharpe Ratio (0.79 vs -0.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.